TR200000033T2 - Oksimorfon, oksikodon ve türevlerinin hazırlanması - Google Patents

Oksimorfon, oksikodon ve türevlerinin hazırlanması

Info

Publication number
TR200000033T2
TR200000033T2 TR2000/00033T TR200000033T TR200000033T2 TR 200000033 T2 TR200000033 T2 TR 200000033T2 TR 2000/00033 T TR2000/00033 T TR 2000/00033T TR 200000033 T TR200000033 T TR 200000033T TR 200000033 T2 TR200000033 T2 TR 200000033T2
Authority
TR
Turkey
Prior art keywords
derivatives
oxymorphone
oxycodone
preparation
noroxymorphone
Prior art date
Application number
TR2000/00033T
Other languages
English (en)
Turkish (tr)
Inventor
Huang Bao-Shan
Christodoulou Aris
Lu Yansong
Ji Ben-Yi
Original Assignee
Penick Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25401603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000033(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Penick Corporation filed Critical Penick Corporation
Publication of TR200000033T2 publication Critical patent/TR200000033T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
TR2000/00033T 1997-07-11 1998-07-10 Oksimorfon, oksikodon ve türevlerinin hazırlanması TR200000033T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/893,464 US5869669A (en) 1996-07-26 1997-07-11 Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates

Publications (1)

Publication Number Publication Date
TR200000033T2 true TR200000033T2 (tr) 2000-12-21

Family

ID=25401603

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00033T TR200000033T2 (tr) 1997-07-11 1998-07-10 Oksimorfon, oksikodon ve türevlerinin hazırlanması

Country Status (19)

Country Link
US (7) US5869669A (forum.php)
EP (1) EP1000065B1 (forum.php)
JP (1) JP2001518444A (forum.php)
KR (1) KR100363486B1 (forum.php)
CN (1) CN1152880C (forum.php)
AT (1) ATE291023T1 (forum.php)
AU (1) AU740822B2 (forum.php)
CA (1) CA2296035C (forum.php)
DE (1) DE69829379D1 (forum.php)
HU (1) HUP0003918A3 (forum.php)
IL (1) IL133792A0 (forum.php)
IN (1) IN1998KO01500A (forum.php)
NO (1) NO20000111L (forum.php)
RU (1) RU2183636C2 (forum.php)
SK (1) SK102000A3 (forum.php)
TR (1) TR200000033T2 (forum.php)
TW (1) TW505648B (forum.php)
WO (1) WO1999002529A1 (forum.php)
ZA (1) ZA986144B (forum.php)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912347A (en) * 1996-09-30 1999-06-15 Mallinckrodt Inc. Process for preparing a morphinan derivative
AU4823900A (en) * 1999-05-05 2000-11-17 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Direct c-14 oxidation of opioids
US6177567B1 (en) * 1999-10-15 2001-01-23 Boehringer Ingelheim Chemicals, Inc. Method for preparing oxycodone
JP4559730B2 (ja) * 2001-08-23 2010-10-13 ナームローゼ・フエンノートチヤツプ・オルガノン １４−ヒドロキシノルモルフィノン誘導体の調製方法。
JP3961796B2 (ja) * 2001-08-27 2007-08-22 ソニー株式会社 情報提供システム、情報処理装置および方法、情報提供装置および方法、記録媒体、並びにプログラム
DE10161963A1 (de) * 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US20040058946A1 (en) * 2002-07-05 2004-03-25 Buchwald Stephen L. Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
RU2236412C2 (ru) * 2002-07-18 2004-09-20 Власов Михаил Иванович Способ получения производных морфинона, способ получения производных 14-гидроксиморфинона, и способ получения производных оксиморфона
RU2215742C1 (ru) * 2002-11-05 2003-11-10 Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" Способ получения сложных эфиров n-замещенных 14-гидроксиморфинанов
RU2215741C1 (ru) * 2002-11-05 2003-11-10 Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" Сложные эфиры n-замещенных 14-гидроксиморфинанов и способ их получения
DE60329520D1 (de) * 2002-11-08 2009-11-12 Mallinckrodt Inc Verfahren zur herstellung von quaternäre n-alkyl morphinan alkaloid salzen
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
US6864370B1 (en) * 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone
US6790959B1 (en) 2003-06-05 2004-09-14 Halsey Drug Company, Inc. Process for manufacturing thebaine
US7875718B2 (en) * 2003-09-22 2011-01-25 Johnson Matthey Public Limited Company Process for the synthesis of morphinane compounds and intermediates thereof
PT1664061T (pt) 2003-09-22 2017-06-22 Glaxosmithkline Australia Pty Ltd Processo para a síntese de compostos de morfinano e seus intermediários
SI1711502T1 (sl) 2004-02-06 2009-02-28 Euro Celtique Sa Postopki za izdelavo 3-O-zaščitenih morfinonov in 3-O-zaščitenih morfinondienol karboksilatov
TWI365880B (en) * 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
SK286047B6 (sk) * 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6946556B1 (en) * 2004-05-21 2005-09-20 Acura Pharmaceuticals, Inc. Preparation of opioid analgesics by a one-pot process
JP2008501797A (ja) * 2004-06-08 2008-01-24 マリンクロッド・インコーポレイテッド アヘンからのアルカロイド類の抽出
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Formulations of medicines to discourage abuse
BRPI0515372B8 (pt) 2004-09-17 2021-05-25 Durect Corp composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
GB0421149D0 (en) * 2004-09-23 2004-10-27 Johnson Matthey Plc Preparation of oxycodone
GB0421687D0 (en) * 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
WO2006084389A1 (de) * 2005-02-11 2006-08-17 Cilag Ltd. Verfahren zur reinigung von noroxymorphon-verbindungen
DE602006018208D1 (de) * 2005-03-04 2010-12-23 Euro Celtique Sa Verfahren zur Verminderung von Alpha, Beta-ungesättigten Ketonen in Opioidzusammensetzungen
EP1873158B1 (en) * 2005-04-06 2016-04-06 Toray Industries, Inc. Crystals of morphinan derivative and process for producing the same
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US8067597B2 (en) * 2005-06-16 2011-11-29 Mallinckrodt Llc Synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
MX2008010921A (es) 2006-03-02 2008-09-03 Mallinckrodt Inc Procesos para preparar productos de morfinan-6-ona con bajos niveles de compuestos de cetona alfa, beta-insaturados.
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP2010504325A (ja) * 2006-09-20 2010-02-12 マリンクロット インコーポレイテッド 置換モルフィナン−６−オン、並びにその塩および中間体の調製
US20080125592A1 (en) * 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
WO2008048711A1 (en) * 2006-10-17 2008-04-24 Penick Corporation Process for preparing oxymorphone
CA2674915C (en) * 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
US7875719B2 (en) * 2006-12-04 2011-01-25 Cox D Phillip Process for reducing impurities in oxycodone base
US7906647B2 (en) * 2006-12-04 2011-03-15 Noramco, Inc. Process for preparing oxycodone having reduced levels of 14-hydroxycodeinone
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
US9040726B2 (en) * 2007-03-06 2015-05-26 Mallinckrodt Llc Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
WO2008109156A2 (en) * 2007-03-06 2008-09-12 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
CA2681740A1 (en) * 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
JP5373764B2 (ja) * 2007-04-16 2013-12-18 マリンクロッド エルエルシー 触媒性水素転移反応を使用する新規なオピエート還元
US20090018154A1 (en) * 2007-05-17 2009-01-15 Endo Pharmaceuticals, Inc., A Corporation Of Delaware Opioid and methods of making and using the same
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
ES2569655T3 (es) 2007-12-17 2016-05-12 Mallinckrodt Llc Procedimientos para la producción de compuestos de (+)-'nal' morfinano
WO2009078988A1 (en) * 2007-12-17 2009-06-25 Mallinckrodt Inc. Sinomenine derivatives and processes for their synthesis
CA2716944A1 (en) 2008-02-29 2009-09-11 Mallinckrodt Inc. Process for the preparation of 3-hydroxymorphinan derivatives
RS52041B (sr) * 2008-04-24 2012-04-30 Janssen Pharmaceutica N.V. Prolekovi nalmefena
JP6027315B2 (ja) * 2008-05-27 2016-11-16 マリンクロッド エルエルシー ノルモルフィナンの調製のための方法および化合物
US9458109B2 (en) 2008-09-03 2016-10-04 Mallinckrodt Llc Substituted berbines and processes for their synthesis
EP2344506B1 (en) * 2008-09-30 2016-02-10 Mallinckrodt LLC Processes for the alkylation of secondary amine groups of morphinan derivatives
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2011154827A2 (en) 2010-06-11 2011-12-15 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
AU2011274361B2 (en) 2010-07-02 2014-09-18 Macfarlan Smith Limited Process for the synthesis and purification of oxycodone
RU2448709C1 (ru) * 2011-02-01 2012-04-27 Учреждение Российской академии наук Институт проблем химико-энергетических технологий Сибирского отделения РАН (ИПХЭТ СО РАН) Способ получения налтрексона
TWI560170B (en) * 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
US9315514B2 (en) 2012-08-27 2016-04-19 Rhodes Technologies 1,3-dioxanomorphides and 1,3-dioxanocodides
TWI513697B (zh) 2012-12-14 2015-12-21 Purdue Pharma Lp 吡啶酮並嗎啡喃類似物及其對類鴉片受體之生物活性
CA2894967A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
WO2014091298A2 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Nitrogen containing morphinan derivatives and the use thereof
CA2896202A1 (en) 2012-12-28 2014-07-03 Purdue Pharma L.P. Substituted morphinans and the use thereof
WO2014102587A1 (en) 2012-12-28 2014-07-03 Purdue Pharma L.P. 7,8-cyclicmorphinan analogs
JP6181770B2 (ja) 2012-12-31 2017-08-16 ローズ テクノロジーズ ７β−置換６α，１４α−エテノモルフィナンおよび７β−置換６α，１４α−エタノモルフィナンを調製するための方法
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
EP2829541A1 (en) * 2013-07-26 2015-01-28 Siegfried AG Novel synthesis of noroxymorphone from morphine
EP3027622B8 (en) 2013-08-02 2019-06-12 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
WO2015097547A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. 10-substituted morphinan hydantoins
WO2015097546A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Propellane-based compounds and their use as opioid receptor modulators
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
US9988392B2 (en) 2013-12-26 2018-06-05 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
WO2015102682A1 (en) 2013-12-30 2015-07-09 Purdue Pharma L.P. Pyridone-sulfone morphinan analogs as opioid receptor ligands
EP3223819A4 (en) 2014-11-25 2018-04-25 Kempharm, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations
CN109475505A (zh) 2016-07-06 2019-03-15 度瑞公司 具有药物组成物、屏障层及药物层的口服剂型
EP3559010B1 (en) 2016-12-23 2022-06-08 Minoryx Therapeutics S.L. Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof
SK592017A3 (sk) 2017-07-04 2019-01-08 Saneca Pharmaceuticals A. S. Spôsob prípravy morfínanových zlúčenín
CN111836813A (zh) 2018-02-23 2020-10-27 罗德科技公司 新型阿片样化合物及其用途
CN110054656B (zh) * 2019-05-28 2021-02-02 宜昌人福药业有限责任公司 一种10-羰基/羟基吗啡-6-葡萄糖苷酸的合成方法
WO2021007366A1 (en) * 2019-07-08 2021-01-14 St. Louis College Of Pharmacy G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN114621239A (zh) * 2020-12-10 2022-06-14 鲁南制药集团股份有限公司 一种纳曲酮的制备方法
EP4267583A4 (en) * 2020-12-28 2024-10-30 Navin Saxena Research & Technology Pvt. Ltd. NEW PROCESS FOR THE PRODUCTION OF NOROXYMORPHONE FROM MORPHINE
EP4277702A1 (en) 2021-01-12 2023-11-22 Durect Corporation Sustained release drug delivery systems and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819636A (en) * 1970-09-15 1974-06-25 American Home Prod 4a,10-(methaniminomethano)phenanthrene derivatives
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine
DE3581423D1 (de) * 1984-03-27 1991-02-28 Mallinckrodt Inc Herstellung von noroxymorphon aus morphin.
US4639520A (en) * 1984-03-27 1987-01-27 Mallinckrodt, Inc. Preparation of 14-hydroxy-N-ethoxy-carbonyl-norcodeinone
US4668685A (en) * 1984-07-05 1987-05-26 E.I. Du Pont De Nemours And Company Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives

Also Published As

Publication number Publication date
US5869669A (en) 1999-02-09
SK102000A3 (en) 2000-07-11
NO20000111D0 (no) 2000-01-10
US5952495A (en) 1999-09-14
AU8379198A (en) 1999-02-08
AU740822B2 (en) 2001-11-15
TW505648B (en) 2002-10-11
US6008354A (en) 1999-12-28
CN1152880C (zh) 2004-06-09
JP2001518444A (ja) 2001-10-16
US6013796A (en) 2000-01-11
WO1999002529A1 (en) 1999-01-21
CN1272845A (zh) 2000-11-08
KR100363486B1 (ko) 2002-12-16
CA2296035C (en) 2004-04-13
HUP0003918A2 (hu) 2001-07-30
CA2296035A1 (en) 1999-01-21
HUP0003918A3 (en) 2003-04-28
EP1000065A4 (en) 2001-09-12
IN1998KO01500A (forum.php) 2005-03-11
DE69829379D1 (de) 2005-04-21
HK1028025A1 (en) 2001-02-02
ZA986144B (en) 1999-05-19
US5948788A (en) 1999-09-07
EP1000065B1 (en) 2005-03-16
ATE291023T1 (de) 2005-04-15
US5922876A (en) 1999-07-13
IL133792A0 (en) 2001-04-30
NO20000111L (no) 2000-02-25
US6008355A (en) 1999-12-28
KR20010021693A (ko) 2001-03-15
RU2183636C2 (ru) 2002-06-20
EP1000065A1 (en) 2000-05-17

Similar Documents

Publication Publication Date Title
TR200000033T2 (tr) Oksimorfon, oksikodon ve türevlerinin hazırlanması
Wentland et al. Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone
WO2000071518A3 (en) Heterocyclic analgesic compounds and their use
PT1020185E (pt) Analgesicos opioides de libertacao controlada
ATE522503T1 (de) Neue opiate, herstellungsverfahren und verwendungen
WO2002036573A2 (en) 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
AU2002227135A1 (en) 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
NZ331119A (en) Isoquinolines useful as analgesics
ID27345A (id) Pencegahan produksi lendir jalan udara dengan antagonis egf-r
EP1053238A4 (en) THERAPEUTIC CONNECTIONS
PL349778A1 (en) Tricyclic benzodiazepines as vasopressin receptor antagonists
NO20016067L (no) Fremgangsmåte for fremstilling av IL-8-reseptor-antagonister
WO2001068604A3 (en) 3-substituted piperidines comprising urea functionality, and methods of use thereof
WO2005113557A8 (en) Method for the catalytic production of hydrocodone and hydromorphone
ATE441649T1 (de) Verwendung von oripavin als ausgangsmaterial für buprenorphin
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
Ninan et al. An improved synthesis of noroxymorphone
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
SG161741A1 (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
ID23410A (id) Senyawa-senyawa amonium kuaterner sebagai antagonis tacikinin
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID20846A (id) Proses produksi senyawa hidrokarbon monoalkenilaromatik
Machara et al. Synthesis of Nalbuphine from Oripavine via N-Demethylation of N-Cyclobutylmethyl Oripavine
EP1194143A4 (en) IL-8 RECEPTOR ANTAGONISTS
Gyulai et al. Synthesis and opioid activity of novel 6-ketolevorphanol derivatives